Thrombophilia and IVF: A Hidden Barrier to Pregnancy and Modern Treatment Approaches

Is the Embryo Implanting but the Pregnancy Not Progressing?

For some couples, one of the most difficult aspects of the IVF journey is experiencing failed pregnancies or recurrent miscarriages despite having high-quality embryos and receiving appropriate treatment. Especially for women who have undergone multiple unsuccessful IVF cycles, one question often arises over time:

“Could there be another underlying problem that has gone unnoticed?”

At this point, thrombophilia becomes an important consideration. Although it often progresses silently without obvious symptoms, it can directly affect the course of pregnancy.

Thrombophilia is a condition in which the blood has an increased tendency to clot more easily than normal. At first glance, it may appear to be solely a vascular disorder. However, it can influence many critical stages of pregnancy—from uterine blood circulation and embryo implantation to placental development and the continuation of a healthy pregnancy.

Thrombophilia may be an important contributing factor, particularly in women who experience:

• Recurrent miscarriages
• Recurrent implantation failure
• Unsuccessful IVF cycles
• A history of biochemical pregnancy
• Unexplained infertility

The most important point to remember is this:

Thrombophilia is a manageable condition when diagnosed accurately and treated appropriately.

What Is Thrombophilia?

Thrombophilia is a condition in which the body has an increased tendency to form blood clots.

Under normal circumstances, blood clotting is a natural protective mechanism that prevents excessive bleeding. However, in some individuals, this mechanism becomes overactive, leading to unnecessary clot formation.

During pregnancy, this condition may cause microscopic circulation problems, particularly within:

• The endometrium (uterine lining)
• The placenta
• The blood vessels responsible for nourishing the developing baby

If adequate blood flow cannot be maintained while the embryo is attempting to implant into the uterine lining, pregnancy may either fail to occur or fail to progress normally, even if implantation initially takes place.

Many women may carry thrombophilia for years without realizing it. In cases without obvious symptoms, the condition is often discovered only after further investigation following:

• Recurrent pregnancy loss
• Repeated IVF failures
• Recurrent implantation failure

What Are the Types of Thrombophilia?

Thrombophilia is generally classified into two main categories.

1. Inherited (Genetic) Thrombophilia

Inherited thrombophilia is associated with genetic mutations present from birth.

These mutations may increase the blood’s tendency to clot more easily than normal.

The most common inherited thrombophilia mutations include:

• Factor V Leiden mutation
• Prothrombin (Factor II) mutation
• MTHFR mutation
• PAI-1 gene mutation

Among these, the MTHFR mutation is relatively common within the general population. However, it is important to understand that not every MTHFR mutation is associated with pregnancy loss. Test results should always be interpreted by an experienced fertility specialist or healthcare professional.

Many women with these genetic mutations remain completely symptom-free for years. However, their effects may become more apparent once pregnancy begins or during IVF treatment.

2. Acquired Thrombophilia

Acquired thrombophilia develops later in life and is most commonly associated with disorders of the immune system.

The most frequently encountered cause is:

Antiphospholipid Syndrome (APS)

In this condition, the immune system may affect the blood vessels, increasing the tendency for abnormal blood clot formation.

APS has been strongly associated with:

• Recurrent miscarriage
• Placental complications
• Recurrent implantation failure
• Unexplained IVF failure

For some women, years of unexplained pregnancy loss may ultimately be found to result from immune system–related thrombophilia.

How Does Thrombophilia Affect IVF Success?

Thrombophilia can influence several stages of the IVF process.

In some cases, the embryo may be of excellent quality and the embryo transfer may appear successful, yet pregnancy does not occur. In other cases, pregnancy may be achieved but fail to progress.

This is where thrombophilia may play a significant role.

1. Impaired Uterine Blood Flow

For an embryo to implant successfully, the uterus requires a healthy and adequate blood supply.

When the tendency for blood clotting increases:

• Blood flow to the uterine lining may decrease.
• The endometrium may not receive sufficient nourishment.
• The uterine environment may become less favorable for embryo implantation.

This condition may be associated with:

• Thin endometrium
• Recurrent implantation failure
• Failed embryo transfer

No matter how high the quality of the embryo is, successful implantation becomes more difficult without a healthy uterine environment.

2. Placental Complications

The effects of thrombophilia may continue even after pregnancy has been established.

Microscopic blood clots developing within the placenta may lead to:

• Reduced nutrient supply to the baby
• Decreased oxygen delivery
• Fetal growth restriction
• An increased risk of miscarriage

For some women, recurrent pregnancy loss may be linked to circulation problems that remain undiagnosed for many years.

3. Recurrent IVF Failure

Thrombophilia assessment becomes particularly important in women who have experienced:

• Two or more unsuccessful IVF cycles
• A history of biochemical pregnancy
• Recurrent implantation failure
• Recurrent miscarriages

Sometimes, the problem is not the quality of the embryo itself, but rather the environment in which the embryo is trying to implant.

What Tests Are Used to Diagnose Thrombophilia?

Before beginning IVF treatment—or following repeated IVF failures—certain genetic and hematological tests may be recommended.

The most commonly performed tests include:

• Factor V Leiden mutation
• Prothrombin G20210A mutation
• MTHFR C677T and A1298C mutations
• PAI-1 gene mutation
• Antiphospholipid antibodies
• Lupus anticoagulant test
• Anticardiolipin antibodies
• Protein C, Protein S, and Antithrombin III levels

These tests help identify potential risks that may affect pregnancy, allowing specialists to develop a personalized treatment strategy before or during IVF.

Modern Approaches to Managing Thrombophilia During IVF

Blood-Thinning Therapy

For women diagnosed with thrombophilia, the most commonly recommended treatment involves anticoagulant (blood-thinning) therapy.

Common medications include:

• Low-dose aspirin
• Heparin injections (such as Clexane®, Fragmin®, and similar medications)

These treatments may help:

• Improve uterine blood circulation
• Reduce the formation of microscopic blood clots
• Support embryo implantation

For many women, beginning the appropriate treatment plan can make the IVF journey feel more controlled and significantly more hopeful.

Vitamin and Supportive Therapies

Supportive nutritional therapy may also play an important role in women with certain genetic mutations.

Commonly recommended supplements include:

• Folic acid
• Vitamin B6
• Vitamin B12
• Omega-3 fatty acids
• Vitamin D

These nutrients may help support vascular health, immune function, and overall reproductive well-being.

Personalized IVF Planning

Not every woman diagnosed with thrombophilia requires the same treatment approach.

This is because every patient is unique, and factors such as:

• Genetic background
• Hormonal balance
• Immune system function
• Uterine health
• Embryo quality

vary from one individual to another.

For this reason, IVF treatment should always be personalized to maximize the chances of achieving a healthy pregnancy.